Drug-resistant tuberculosis in HIV-infected patients in a national referral hospital, Phnom Penh, Cambodia

References

• Murray JF. A century of tuberculosis. Am J Respir Crit Care Med. 2004; 169: 1181–6. [PubMed Abstract].
   Google Scholar
• World Health Organization. Report: global tuberculosis control 2013. 2013; Geneva, Switzerland: WHO.
   Google Scholar
• Wells CD, Cegielski JP, Nelson LJ, Laserson KF, Holtz TH, Finlay A, etal. HIV infection and multi-drug resistant tuberculosis – the perfect storm. J Infect Dis. 2007; 196: S86–106. [PubMed Abstract].
   Google Scholar
• World Health Organization. Multidrug and extensively-drug resistant TB (M/XDR TB): 2010 global report on surveillance and response. 2010; Geneva, Switzerland: WHO.
   Google Scholar
• Yamada N, Saorith K, Yamakami K, Onozaki I, Boran S, Fujiki A, etal. The national tuberculosis drug resistance survey in Cambodia, 2000–2001. Int J Tuberc Lung Dis. 2007; 11: 1321–7. [PubMed Abstract].
   Google Scholar
• Blanc FX, Sok T, Laureillard D, Borand L, Rekacewicz C, Nerrienet E, etal. Earlier versus later start of antiretroviral therapy in HIV-infected adults with tuberculosis. N Engl J Med. 2011; 365: 1471–81. [PubMed Abstract].
   Google Scholar
• Sar B, Keo C, Leng C, Saman M, Min DC, Chan S, etal. Anti-tuberculosis drug resistance and HIV co-infection in Phnom Penh, Cambodia. Southeast Asian J Trop Med Public Health. 2009; 40: 104–7. [PubMed Abstract].
   Google Scholar
• Kimerling ME, Schuchter J, Chanthol E, Kunthy T, Stuer F, Glaziou P, etal. Prevalence of pulmonary tuberculosis among HIV-infected persons in a home care program in Phnom Penh, Cambodia. Int J Tuberc Lung Dis. 2002; 6: 988–94. [PubMed Abstract].
   Google Scholar
• Varaine F, Henkens M, Grovzard V. Tuberculosis. Practical guidelines for clinicians, nurses, laboratory technicians and medical auxiliaries. 2008; 5th ed, Paris, France: Médecins Sans Frontières.
   Google Scholar
• World Health Organization. Treatment of tuberculosis: guidelines. 2010; 4th ed, Geneva, Switzerland: WHO.
   Google Scholar
• World Health Organization. Guidelines for the programmatic management of drug-resistant tuberculosis. 2006; Geneva, Switzerland: WHO.
   Google Scholar
• Mannheimer SB, Sepkowitz KA, Stoekle M, Friedman CR, Hofner A, Riley LW. Risk factors and outcome of human immunodeficiency virus-infected patients with sporadic MDR TB in New York City. Int J Tuberc Lung Dis. 1997; 1: 319–25. [PubMed Abstract].
   Google Scholar
• Reid A, Scano F, Getahun H, Williams B, Dye C, Nunn P, etal. Towards universal access to HIV prevention, treatment, care and support: the role of tuberculosis/HIV collaboration. Lancet Infect Dis. 2006; 6: 483–95. [PubMed Abstract].
   Google Scholar
• Suchindran S, Brouwer ES, Van Rie A. Is HIV infection a risk factor for multi-drug resistant tuberculosis? A systematic review. PLoS One. 2009; 4: e5561. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Ghandi NR, Moll A, Sturm AW, Pawinski R, Govender T, Lalloo U, etal. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet. 2006; 368: 1575–80.
   PubMed Web of Science ®Google Scholar
• Frieder TR, Sherman LF, Maw KL, Fujiwara PI, Crawford JT, Nivin B, etal. A multi-institutional outbreak of highly drug resistant tuberculosis: epidemiology and clinical outcomes. JAMA. 1996; 276: 1229–35.
   Web of Science ®Google Scholar
• Sanchez-Padilla E, Dlamini T, Ascorra A, Rusch-Gerdes S, Tefera ZD, Calain P, etal. High prevalence of multidrug-resistant tuberculosis, Swaziland, 2009–2010. Emerg Infect Dis. 2012; 18: 29–37. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, etal. Rapid molecular detection of tuberculosis and rifampicin resistance. N Engl J Med. 2010; 363: 1005–15. [PubMed Abstract] [PubMed CentralFull Text].
   Google Scholar
• Barnard M, Albert H, Coetzee G, O'Brien R, Bosman ME. Rapid molecular screening for multi-drug resistant tuberculosis in a high volume public health laboratory in South Africa. Am J Resp Crit Care Med. 2008; 177: 787–92. [PubMed Abstract].
   Google Scholar
• Nathanson E, Nunn P, Uplekar M, Floyd K, Jaramillo E, Lonnroth K, etal. MDR tuberculosis – critical steps for prevention and control. N Engl J Med. 2010; 363: 1050–8. [PubMed Abstract].
   Google Scholar
• Marcy O, Laureillard D, Madec Y, Chan S, Mayaud C, Borand L, etal. Causes and determinants of mortality in HIV-infected adults with tuberculosis: an analysis from the CAMELIA ANRS 1295-CIPRA KH001 randomized trial. Clin Infect Dis. 2014; 59: 435–45. [PubMed Abstract].
   Google Scholar
• McNerney R, Maeurer M, Abubakar I, Marais B, McHugh TD, Ford N, etal. Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities. J Infect Dis. 2012; 205: S147–58. [PubMed Abstract].
   Google Scholar
• Yang Z, Kong Y, Wilson F, Foxman B, Fowler AH, Marrs CF, etal. Identification of risk factors for extrapulmonary tuberculosis. Clin Infect Dis. 2004; 38: 199–205. [PubMed Abstract].
   Google Scholar